GlassScriptPhysician profile
Lindsey L Parrish
NPI 1508227570
$738.73
in general payments reported to CMS, 2019-2025
13 companies · $212 in 2025
The $212 reported for 2025 was more than what 76% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $63.48 · 2022: $141 · 2023: $148 · 2024: $174 · 2025: $212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $535.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $534.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $284.52 | 2022-2025 | Azstarys |
| Sanofi-Aventis U.S. LLC | $88.60 | 2024-2025 | |
| Pfizer INC. | $87.00 | 2023-2025 | |
| Kaleo, INC. | $40.15 | 2022 | |
| Tris Pharma INC | $38.97 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $38.28 | 2022-2025 | Vaxneuvance, Gardasil 9, Enflonsia |
| Collegium Pharmaceutical, INC. | $34.85 | 2025 | Jornay Pm |
| Supernus Pharmaceuticals, INC. | $29.10 | 2021 | |
| Seqirus USA INC | $27.26 | 2025 | Flucelvax |
| Biogen, INC. | $19.16 | 2023 | Spinraza |
| Biomarin Pharmaceutical INC. | $18.38 | 2024 | Voxzogo 1.2mg |
| Sobi, INC | $17.88 | 2021 | |
| Neos Therapeutics, LP | $14.58 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lindsey Parrish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.